Revised SPCs: Tivicay (dolutegravir sodium) film-coated tablets – all strengths

Dolutegravir is now also available in dispersible tablets for children aged ≥4 weeks, weighing > 3 kg. Elevated bilirubin levels added as a rare (≥1/10,000 to <1/1,000) side-effect of treatment.

Source:

electronic Medicines compendium